AM-102 (Auris Medical Holding/Zilentin)

N/A

Report date: 2025/01/26 16:49:47
NME

Base Information

Drug NameAM-102 (Auris Medical Holding/Zilentin)
Drug Alias NameNKCC1 inhibitor (Auris Medical Holding/Zilentin)Na-K-Cl cotransporter isoform 1 inhibitor (Auris Medical Holding/Zilentin)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSolute carrier family 12 member 2 blockers
TargetsSolute carrier family 12 member 2
Therapy Area/IndicationsTinnitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAltamira Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZilentin AgAltamira Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsTinnitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A